Developments CureVac unveils restructuring plan to intensify focus on mRNA projects CureVac (NASDAQ:CVAC) has announced a restructuring plan aimed at increasing its focus on high-value messenger RNA (mRNA) initiatives, with a particular emphasis on oncology and unmet medical needs. The company will... July 5, 2024